The locus of Epstein-Barr virus terminal repeat processing is bound with enhanced affinity by Sp1 and Sp3

Virology

Volumn 237, Issue 1, 1997, Pages 137-147

  Spain, Tammy A ^a   Sun, Ren ^a   Miller, George ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE LOCUS; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; TANDEM REPEAT; TRANSCRIPTION INITIATION;

HUMAN HERPESVIRUS 4;

EID: 0030669003     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8770     Document Type: Article

References (56)

1. Adams A., Lindahl T. Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells. Proc. Natl. Acad. Sci. USA. 72:1975;1477-1481.
2. Baer R., Bankier A. T., Biggin M. D., Deininger P. L., Farrell P. J., Gibson T. J., Hatfull G., Hudson G. S., Satchwell S. C., Seguin C. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature. 310:1984;207-211.
3. Blier P. R., Griffith A. J., Craft J., Hardin J. A. Binding of Ku protein to DNA. Measurement of affinity for ends and demonstration of binding to nicks. J. Biol. Chem. 268:1993;7594-7601.
4. Boubnov N. V., Hall K. T., Wills Z., Lee S. E., He D. M., Benjamin D. M., Pulaski C. R., Band H., Reeves W., Hendrickson E. A. Complementation of the ionizing radiation sensitivity, DNA end binding, and V(D)J recombination defects of double-strand break repair mutants by the p86 Ku autoantigen. Proc. Natl. Acad. Sci. USA. 92:1995;890-894.
5. Courey A. J., Tjian R. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell. 55:1988;887-898.
6. J. Craft, J. Hardin, 1992, Immunoprecipitation assays for the detection of soluble nuclear and cytoplasmic nucleoproteins, Manual of Clinical Laboratory Immunology, 747, 754, Am. Soc. Microbiol. Washington, DC.
7. Di Nocera P. P., Dawid I. B. Transient expression of genes introduced into cultured cells of Drosophila. Proc. Natl. Acad. Sci. USA. 80:1983;7095-7098.
8. Dittmer J., Gegonne A., Gitlin S. D., Ghysdael J., Brady J. N. Regulation of parathyroid hormone-related protein (PTHrP) gene expression. Sp1 binds through an inverted CACCC motif and regulates promoter activity in cooperation with Ets1. J. Biol. Chem. 269:1994;21428-21434.
9. Doyle M. G., Catovsky D., Crawford D. H. Infection of leukaemic B lymphocytes by Epstein-Barr virus. Leukemia. 7:1993;1858-1864.
10. Errami A., Smider V., Rathmell W. K., He D. M., Hendrickson E. A., Zdzienicka M. Z., Chu G. Ku86 defines the genetic defect and restores X-ray resistance and V(D)J recombination to complementation group 5 hamster cell mutants. Mol. Cell Biol. 16:1996;1519-1526.
11. Gardella T., Medveczky P., Sairenji T., Mulder C. Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis. J. Virol. 50:1984;248-254.
12. Given D., Yee D., Griem K., Kieff E. DNA of Epstein-Barr virus. V. Direct repeats of the ends of Epstein-Barr virus DNA. J. Virol. 30:1979;852-862.
13. Gottlieb T. M., Jackson S. P. The DNA-dependent protein kinase: Requirement for DNA ends and association with Ku antigen. Cell. 72:1993;131-142.
14. Grogan E. A., Summers W. P., Dowling S., Shedd D., Gradoville L., Miller G. Two Epstein-Barr viral nuclear neoantigens distinguished by gene transfer, serology, and chromosome binding. Proc. Natl. Acad. Sci. USA. 80:1983;7650-7653.
15. Gussander E., Adams A. Electron microscopic evidence for replication of circular Epstein-Barr virus genomes in latently infected Raji cells. J. Virol. 52:1984;549-556.
16. Hagen G., Muller S., Beato M., Suske G. Cloning by recognition site screening of two novel GT box binding proteins: A family of Sp1 related genes. Nucleic Acids Res. 20:1992;5519-5525.
17. Hagen G., Muller S., Beato M., Suske G. Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J. 13:1994;3843-3851.
18. Hammerschmidt W., Sugden B. Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell. 55:1988;427-433.
19. Hardin C. C., Henderson E., Watson T., Prosser J. K. Monovalent cation induced structural transitions in telomeric DNAs: G-DNA folding intermediates. Biochemistry. 30:1991;4460-4472.
20. Hardin C. C., Watson T., Corregan M., Bailey C. Cation-dependent transition between the quadruplex and Watson-Crick hairpin forms of d(CGCG3GCG). Biochemistry. 31:1992;833-841.
21. Hurley E. A., Thorley-Lawson D. A. B cell activation and the establishment of Epstein-Barr virus latency. J. Exp. Med. 168:1988;2059-2075.
22. Jeang K. T., Hayward S. D. Organization of the Epstein-Barr virus DNA molecule. III. Location of the P3HR-1 deletion junction and characterization of the NotI repeat units that form part of the template for an abundant 12-O-tetradecanoylphorbol-13-acetate-induced mRNA transcript. J. Virol. 48:1983;135-148.
23. Kadonaga J. T., Carner K. R., Masiarz F. R., Tjian R. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell. 51:1987;1079-1090.
24. Kadonaga J. T., Jones K. A., Tjian R. Promoter-specific activation of RNA polymerase II transcription by Sp1. Trends Biochem. Sci. 11:1986;20-23.
25. Kingsley C., Winoto A. Cloning of GT box-binding proteins: A novel Sp1 multigene family regulating T-cell receptor gene expression. Mol. Cell Biol. 12:1992;4251-4261.
26. Kintner C. R., Sugden B. The structure of the termini of the DNA of Epstein-Barr virus. Cell. 17:1979a;661-671.
27. Kintner C. R., Sugden B. The structure of the termini of the DNA of Epstein-Barr virus. Cell. 17:1979b;661-671.
28. Klein E., Klein G., Nadkarni J. S., Nadkarni J. J., Wigzell H., Clifford P. Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Res. 28:1968;1300-1310.
29. Kudo S., Fukuda M. Transcriptional activation of human leukosialin (CD43) gene by Sp1 through binding to a GGGTGG motif. Eur. J. Biochem. 223:1994;319-327.
30. Majello B., De Luca P., Hagen G., Suske G., Lania L. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1. Nucleic Acids Res. 22:1994;4914-4921.
31. Majello B., De Luca P., Suske G., Lania L. Differential transcriptional regulation of c-myc promoter through the same DNA binding sites targeted by Sp1-like proteins. Oncogene. 10:1995;1841-1848.
32. Marin M., Karis A., Visser P., Grosveld F., Philipsen S. Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation. Cell. 89:1997;619-628.
33. Miller G., Grogan E., Rowe D., Rooney C., Heston L., Eastman R., Andiman W., Niederman J., Lenoir G., Henle W. Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infection. J. Infect. Dis. 156:1987;26-35.
34. Miller G., Lipman M. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. USA. 70:1973;190-194.
35. Mortlock D. P., Nelson M. R., Innis J. W. An efficient method for isolating putative promoters and 5′-transcribed sequences from large genomic clones. Genome Res. 6:1996;327-335.
36. Nonoyama M., Pagano J. S. Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells. Nature New Biol. 238:1972;169-171.
37. Okumura K., Sakaguchi G., Takagi S., Naito K., Mimori T., Igarashi H. Sp1 family proteins recognize the U5 repressive element of the long terminal repeat of human T cell leukemia virus type I through binding to the CACCC core motif. J. Biol. Chem. 271:1996;12944-12950.
38. Pulvertaft R. J. V. Cytology of Burkitt's Tumour (African Lymphoma). Lancet. 1:1964;238-240.
39. Rabson M., Heston L., Miller G. Identification of a rare Epstein-Barr virus variant that enhances early antigen expression in Raji cells. Proc. Natl. Acad. Sci. USA. 80:1983;2762-2766.
40. Sadler R. H., Raab-Traub N. The Epstein-Barr virus 3.5-kilobase latent membrane protein 1 mRNA initiates from a TATA-less promoter within the first terminal repeat. J. Virol. 69:1995;4577-4581.
41. Schneider I. Cell lines derived from late embryonic stages of Drosophila melanogaster. J. Embryol. Exp. Morphol. 27:1972;353-365.
42. Sen D., Gilbert W. Formation of parallel four-stranded complexes by guanine-rich motifs in DNA and its implications for meiosis. Nature. 334:1988;364-366.
43. Sen D., Gilbert W. Guanine quartet structures. Methods Enzymol. 211:1992;191-199.
44. Smider V., Rathmell W. K., Lieber M. R., Chu G. Restoration of X-ray resistance and V(D)J recombination in mutant cells by Ku cDNA. Science. 266:1994;288-291.
45. Smith F. W., Feigon J. Quadruplex structure of Oxytricha telomeric DNA oligonucleotides. Nature. 356:1992;164-168.
46. Spain T. A., Sun R., Gradzka M., Lin S.-F., Craft J., Miller G. The transcriptional activator Sp1 is an autoantigen. Arthritis Rheum. 1997.
47. Strachan T. The Human Genome. Read A. P., Brown T. The Medical Perspectives Series. 1992;BIOS Scientific Publishers Limited, Oxford.
48. Sun R., Spain T. A., Lin S.-F., Miller G. Sp1 binds to the precise locus of end processing within the terminal repeats of Epstein-Barr viral DNA. J. Virol. 1997.
49. Sun R., Spain T. A., Lin S. F., Miller G. Autoantigenic proteins that bind recombinogenic sequences in Epstein-Barr virus and cellular DNA. Proc. Natl. Acad. Sci. USA. 91:1994;8646-8650.
50. Taccioli G. E., Gottlieb T. M., Blunt T., Priestley A., Demengeot J., Mizuta R., Lehmann A. R., Alt F. W., Jackson S. P., Jeggo P. A. Ku80: Product of the XRCC5 gene and its role in DNA repair and V(D)J recombination. Science. 265:1994;1442-1445.
51. Walls E. V., Doyle M. G., Patel K. K., Allday M. J., Catovsky D., Crawford D. H. Activation and immortalization of leukaemic B cells by Epstein-Barr virus. Int. J. Cancer. 44:1989;846-853.
52. Wang J., Chou C. H., Blankson J., Satoh M., Knuth M. W., Eisenberg R. A., Pisetsky D. S., Reeves W. H. Murine monoclonal antibodies specific for conserved and non-conserved antigenic determinants of the human and murine Ku autoantigens. Mol. Biol. Rep. 18:1993;15-28.
53. Weigel R., Miller G. Major EB virus-specific cytoplasmic transcripts in a cellular clone of the HR-1 Burkitt lymphoma line during latency and after induction of viral replicative cycle by phorbol esters. Virology. 125:1983;287-298.
54. Zhang W. W., Yaneva M. On the mechanisms of Ku protein binding to DNA. Biochem. Biophys. Res. Commun. 186:1992;574-579.
55. Zhu C., Bogue M. A., Lim D. S., Hasty P., Roth D. B. Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell. 86:1996;379-389.
56. Zimmermann J., Hammerschmidt W. Structure and role of the terminal repeats of Epstein-Barr virus in processing and packaging of virion DNA. J. Virol. 69:1995;3147-3155.